Order Article Reprints

Oshi M, Takahashi H, Tokumaru Y, Yan L, Rashid OM, Nagahashi M, Matsuyama R, Endo I, Takabe K. The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2− Breast Cancer. Cells. 2020; 9(7):1643. https://doi.org/10.3390/cells9071643

Oshi, Masanori, Hideo Takahashi, Yoshihisa Tokumaru, Li Yan, Omar M. Rashid, Masayuki Nagahashi, Ryusei Matsuyama, Itaru Endo, and Kazuaki Takabe. 2020. "The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2− Breast Cancer" Cells 9, no. 7: 1643. https://doi.org/10.3390/cells9071643

Oshi, M., Takahashi, H., Tokumaru, Y., Yan, L., Rashid, O. M., Nagahashi, M., Matsuyama, R., Endo, I., & Takabe, K. (2020). The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2− Breast Cancer. Cells, 9(7), 1643. https://doi.org/10.3390/cells9071643